January By Esther Nakkazi On 19, health employees at an HIV treatment facility work by Mildmay Uganda began vaccinating 500 HIV-positive ladies between the ages of 9 and 13 against the cancer-causing human being papillomavirus . The advertising campaign makes the clinic operate by Mildmay, a global not-for-profit Christian business, the first treatment middle specialized in HIV to vaccinate for HPV in Uganda. AIDS clinics are poised with an important function in providing essential infrastructure for delivery of the vaccine, Gardasil, which is made by Merck and protects against cervical cancer http://dmae.xyz/ .) HPV Vaccine, Gardasil Image: Jan Christian, Wikimedia.
Cancer treatment interferes with bone development According to researchers in the U.S. The malignancy drug Gleevec , which has dramatically improved survival leads for a few cancer patients, can interfere with bone development. Gleevec is the treatment of preference for patients with chronic myeloid leukemia and gastrointestinal stromal tumors . Gleevec is considered to be a well tolerated medication, however, unwanted effects do happen, including a number of skin reactions in approximately 10 percent of patients, joint effusions, hypopigmentation, renal dysfunction, hepatic dysfunction, anemia and myelosuppression. Related StoriesCornell biomedical engineers develop 'super natural killer cells' to destroy cancer cells in lymph nodesMD Anderson research reveals why chemotherapy medicines not effective for most pancreatic cancers patientsNew antenna-like gadget makes breast cancer medical procedures easier for surgeonsThe experts from the Memorial Sloan-Kettering Cancer Middle in NY say that some patients acquiring Gleevec develop hypophosphatemia which inhibits bone formation and resorption, an activity known as bone remodelling.